STAT3 and breast cancer: After treatment with doxorubicin, patient samples showed an upregulation of STAT3 which was suppressed when doxorubicin was given with FTY720. Doxorubicin-resistant breast cancer cell lines showed a high expression of SphK1 which was inhibited with the help of FTY720 causing a decrease in growth